Cargando…

Erratum: Proteomics and liquid biopsy characterization of human EMT-related metastasis in colorectal cancer

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769702/ https://www.ncbi.nlm.nih.gov/pubmed/36568180 http://dx.doi.org/10.3389/fonc.2022.1085628

Ejemplares similares

Proteomics and liquid biopsy characterization of human EMT-related metastasis in colorectal cancer
por: Huang, Mao-Sen, et al.
Publicado: (2022)

Editorial: Recent advances in liquid biopsy in colorectal cancer
por: Cardone, Claudia, et al.
Publicado: (2022)

The Interaction Between Epigenetic Changes, EMT, and Exosomes in Predicting Metastasis of Colorectal Cancers (CRC)
por: Yang, Meiqi, et al.
Publicado: (2022)

Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer Centers
por: Fischer, Laura E., et al.
Publicado: (2022)

VCAM1 Promotes Tumor Cell Invasion and Metastasis by Inducing EMT and Transendothelial Migration in Colorectal Cancer
por: Zhang, Dan, et al.
Publicado: (2020)

Liquid biopsy can cure early colorectal cancer recurrence – Case Report
por: Baraniskin, Alexander, et al.
Publicado: (2023)

Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?
por: Mirza, Sheefa, et al.
Publicado: (2023)

SPNS2 Downregulation Induces EMT and Promotes Colorectal Cancer Metastasis via Activating AKT Signaling Pathway
por: Lv, Lei, et al.
Publicado: (2021)

Erratum: Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
Publicado: (2023)

Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches
por: Ceccon, Carlotta, et al.
Publicado: (2022)

Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients
por: Mariani, Stefano, et al.
Publicado: (2022)

Liquid Biopsies in Progressing Metastatic Colorectal Cancer- Application and their Therapeutic Implications According to the RAS Status
por: Pereira, José, et al.
Publicado: (2020)

Platelet detection as a new liquid biopsy tool for human cancers
por: Chen, Maoshan, et al.
Publicado: (2022)

Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer
por: Klein-Scory, Susanne, et al.
Publicado: (2020)

Application progress of liquid biopsy in gastric cancer
por: Ma, Xiaoting, et al.
Publicado: (2022)

Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis
por: Vasilogianni, Areti-Maria, et al.
Publicado: (2023)

Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy
por: Magbanua, Mark Jesus M., et al.
Publicado: (2022)

Editorial: The impact of liquid biopsies in the management of liver cancer
por: Labgaa, Ismail
Publicado: (2022)

The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
por: Freitas, Cláudia, et al.
Publicado: (2021)

Advances in the Detection of Pancreatic Cancer Through Liquid Biopsy
por: Yan, Tian-Bao, et al.
Publicado: (2021)

Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer
por: Internò, Valeria, et al.
Publicado: (2020)

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)

Potential utility of miRNAs for liquid biopsy in breast cancer
por: Liu, Xiangrong, et al.
Publicado: (2022)

Proteomics technologies for cancer liquid biopsies
por: Ding, Zhiyong, et al.
Publicado: (2022)

ENO1 contributes to 5-fluorouracil resistance in colorectal cancer cells via EMT pathway
por: Gu, Jinrong, et al.
Publicado: (2022)

Asporin Interacts With HER2 to Promote Thyroid Cancer Metastasis via the MAPK/EMT Signaling Pathway
por: Zhan, Shaohua, et al.
Publicado: (2022)

GDF15 promotes EMT and metastasis in colorectal cancer
por: Li, Chen, et al.
Publicado: (2015)

Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis
por: Vu, Trung, et al.
Publicado: (2017)

Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient’s Stratification
por: Ginghina, Octav, et al.
Publicado: (2022)

Evaluation of colorectal cancer liver metastases based on liquid biopsy combined with folate receptor– Positive circulating tumor cells and HSP90
por: Huang, Maosen, et al.
Publicado: (2022)

Therapeutically Targeting Cancers That Overexpress FOXC1: A Transcriptional Driver of Cell Plasticity, Partial EMT, and Cancer Metastasis
por: Ray, Tania, et al.
Publicado: (2021)

CircCSPP1 Functions as a ceRNA to Promote Colorectal Carcinoma Cell EMT and Liver Metastasis by Upregulating COL1A1
por: Wang, Qingyuan, et al.
Publicado: (2020)

Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma
por: Yang, Jin-Cui, et al.
Publicado: (2022)

Case report: Liquid biopsy, the sooner the better?
por: Thomas, Quentin Dominique, et al.
Publicado: (2022)

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions
por: Zhang, Zhuo, et al.
Publicado: (2015)

Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
por: Di Nunno, Vincenzo, et al.
Publicado: (2018)

Liquid Biopsy in Oligometastatic Prostate Cancer—A Biologist's Point of View
por: Stelcer, Ewelina, et al.
Publicado: (2019)

Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer
por: Satyal, Uttam, et al.
Publicado: (2019)

The Metastatic Cascade as the Basis for Liquid Biopsy Development
por: Eslami-S, Zahra, et al.
Publicado: (2020)

A Prognosis Marker SLC2A3 Correlates With EMT and Immune Signature in Colorectal Cancer
por: Gao, Huabin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mrpa0sgs0paia3igc1ti369r5d